Multiple Drug Resistance (MDR) is a major reason for failure of cancer chemotherapy. Earlier studies on murine cell lines have identified certain biochemical mechanisms (e.g. rapid drug efflux) responsible for MDR. Cellular markers such as cell surface glycoproteins are often associated with MDR. Our knowledge about MDR in solid tumors is limited and it is important to study drug resistance in human soild tumors, as more often than not, MDR results in treatment failure. In the present study, we propose to study MDR in human solid tumor cells isolated from ascites and pleural fluid of patients and from xenografts earlier established. We will use our laser excitation method to sort and study tumor cells on the basis of their anthracycline fluorescence content. Drug transport characteristics will be studied with or without exposure to drug efflux blockers. Biochemical mechanisms responsible for MDR as well as well-known markers of MDR will be studied. It is hoped that the studies proposed will provide insights into mechanisms involved in MDR of human solid tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044737-03
Application #
3187515
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1987-05-01
Project End
1992-04-30
Budget Start
1989-05-01
Budget End
1990-04-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33101
Isobe, H; Sridhar, K S; Doria, R et al. (1995) Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma. Cytometry 19:86-91
Collins, K; Matsudaira, P T (1995) Recombinant expression of the brush border myosin I heavy chain. Cell Motil Cytoskeleton 32:151-61
Sridhar, K S; Krishan, A; Samy, T S et al. (1993) Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies. Cancer Chemother Pharmacol 31:423-30
Ramachandran, C; Sauerteig, A; Sridhar, K S et al. (1993) MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. Cancer Chemother Pharmacol 31:431-41
Krishan, A; Sauerteig, A; Stein, J H (1991) Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry 12:731-42
Nair, S; Singh, S V; Krishan, A (1991) Flow cytometric monitoring of glutathione content and anthracycline retention in tumor cells. Cytometry 12:336-42
Singh, S V; Iqbal, J; Krishan, A (1990) Cytochrome P450 reductase, antioxidant enzymes and cellular resistance to doxorubicin. Biochem Pharmacol 40:385-7
Singh, S V; Ahmad, H; Krishan, A (1990) Expression of glutathione-related enzymes in human bladder cancer cell lines. Biochem Pharmacol 39:1817-20
Singh, S V; Brunnert, S R; Roberts, B et al. (1990) Differential expression of glutathione S-transferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissues. Cancer Lett 51:43-8
Singh, S V; Nair, S; Ahmad, H et al. (1989) Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells. Biochem Pharmacol 38:3505-10